A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism

Aging Clinical and Experimental Research

Volumn 15, Issue 6, 2003, Pages 500-504

  Ammann, Patrick ^a   Herter Clavel, Catherine ^a   Lubrano, Alessandro ^a   Rizzoli, René ^a  

^a University Hospital   (Switzerland)

Author keywords

Bisphosphonates bone resorption; Clodronate; Elderly; Functional independence measure; Hypercalcemia; Pamidronate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE;

AGED; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPERCALCEMIA; INDEPENDENCE; MALE; OSTEOLYSIS; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 0842325041     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03327373     Document Type: Article

References (25)

1. Mallette LE. Review: primary hyperparathyroidism and update: incidence, etiology, diagnosis, and treatment. Am J Med Sci 1987; 293: 239-49.
2. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 2036-40.
3. Bilezikian JP. Primary hyperparathyroidism. In Favus MJ, Ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, Philadelphia: Lippincott Williams & Wilkins, 1999: 187-92.
4. Kristoffersson A, Bostrom A, Soderberg T. Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 1992; 79: 165-8.
5. Chou FF, Sheen-Chen SM, Leong CP. Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism. Surgery 1995; 117: 18-25.
6. Colliander EB, Strigard K, Westblad P, Rolf C, Nordenstrom J. Muscle strength and endurance after surgery for primary hyperparathyroidism. Eur J Surg 1998; 164: 489-94.
7. Deutch SR, Jensen MB, Christiansen PM, Hessov I. Muscular performance and fatigue in primary hyperparathyroidism. World J Surg 2000; 24: 102-7.
8. Joborn C, Hetta J, Lind L, Rastad J, Akerstrom G, Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 1989; 105: 72-8.
9. Okamoto T, Gerstein HC, Obara T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J 1997; 44: 367-74.
10. Kochersberger G, Buckley NJ, Leight GS, et al. What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 1987; 147: 1951-3.
11. Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O'Fallon WM, Riggs BI. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 1999; 14: 1700-7.
12. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism, with or without parathyroid surgery. N Engl J Med 1999; 341: 1249-55.
13. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989; 4: 283-91.
14. Bijvoet OL, Morgan DB, Fourman P. The assessment of phosphate reabsorption. Clin Chim Acta 1969; 26: 15-24.
15. Buchs B, Rizzoli R, Bonjour JP. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia. Bone 1991; 12: 47-56.
16. Minaire P. La mesure d'indépendance fonctionnelle (M.I.F). Historique, présentation, perspectives. Journal de la Réadaptation Médicale 1991; 11: 168-74.
17. Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD. Performance profiles of the functional independence measure. Am J Phys Med Rehabil 1993; 72: 84-9.
18. Ottenbacher KJ, Mann WC, Granger CV, Tomita M, Hurren D, Charvat B. Inter-rater agreement and stability of functional assessment in the community-based elderly. Arch Phys Med Rehabil 1994; 75: 1297-301.
19. Pollak N, Rheault W, Stoecker JL. Reliability and validity of the FIM for persons aged 80 years and above from a multilevel continuing care retirement community. Arch Phys Med Rehabil 1996; 77: 1056-61.
20. Stineman MG, Shea JA, Jette A, et al. The Functional Independence Measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil 1996; 77: 1101-8.
21. Inabnet WB, Fulla Y, Richard B, Bonnichon P, Icard P, Chapuis Y. Unilateral neck exploration under local anesthesia: the approach of choice for asymptomatic primary hyperparathyroidism. Surgery 1999; 126: 1004-9.
22. Schwarz P, Sorensen HA, Momsen G, McNair P, Transbol I. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study. Clin Endocrinol (Oxf) 1992; 37: 344-8.
23. Adami S, Mian M, Bertoldo F, et al. Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment. Clin Endocrinol (Oxf) 1990; 33: 391-7.
24. Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res 2001; 16: 113-9.
25. Marcus R. Diagnosis and treatment of hyperparathyroidism. Rev Endocr Metab Disord 2000; 1: 247-52.